Volume 46, Issue 6 p. 2047
Correspondence
Free Access

Reply:

Francesca Bravi

Francesca Bravi

Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy

Search for more papers by this author
Cristina Bosetti

Cristina Bosetti

Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy

Search for more papers by this author
Carlo La Vecchia

Carlo La Vecchia

Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy

Istituto di Statistica Medica e Biometria, Università degli Studi di Milano, Milan, Italy

Search for more papers by this author
First published: 28 November 2007

Potential conflict of interest: Nothing to report.

Drs. Patil and Mallath suggest that the variability of caffeine metabolism may partly or largely explain the inverse relation between coffee and hepatocellular carcinoma observed in several studies and quantified in our meta-analysis.1

Apart from genetic variability, we also noted in our discussion that a broad spectrum of digestive tract and liver disorders may lead to changes in caffeine metabolism and hence to a reduction in coffee consumption. Thus, such a variability in metabolism may be both genetic and disease-induced. This is the major difficulty in the interpretation of these findings, as already discussed in our paper.

Francesca Bravi*, Cristina Bosetti*, Carlo La Vecchia* , * Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy, Istituto di Statistica Medica e Biometria, Università degli Studi di Milano, Milan, Italy.

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.